Oncolix, Inc. — Form D

Oncolix, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2015-01-22. The offering totals $6.5M, of which $4.5M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2015-01-22
• Form: D
• Accession: 0001574061-15-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $6.5M
• Amount sold: $4.5M
• Remaining: $2.0M
• Minimum investment: $25K
• Investors: 5
• Date of first sale: 2015-01-16
• Security types: equity
• Revenue range: No Revenues
• SEC file number: 021-232688

Issuer

• Name: Oncolix, Inc.
• CIK: 0001574061
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 14405 WALTERS ROAD, SUITE 780, HOUSTON, TX, 77014
• Phone: 281-402-3169

Officers, directors & promoters (10)

Other filings by this issuer (6)

More

• CIK 1574061 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search